| Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance E Cacan, MW Ali, NH Boyd, SB Hooks, SF Greer PloS one 9 (1), e87455, 2014 | 112 | 2014 |
| Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells MW Ali, E Cacan, Y Liu, JY Pierce, WT Creasman, MM Murph, ... PloS one 8 (3), e60185, 2013 | 57 | 2013 |
| Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells E Cacan Journal of Chemotherapy 29 (3), 173-178, 2017 | 44 | 2017 |
| Differential expression and copy number variation of gasdermin (GSDM) family members, pore-forming proteins in pyroptosis, in normal and malignant serous ovarian tissue C Berkel, E Cacan Inflammation 44 (6), 2203-2216, 2021 | 42 | 2021 |
| Anti-cancer and anti-fungal evaluation of novel palladium (II) 1-phenyl-1H-tetrazol-5-thiol complexes ASM Al-Janabi, MA Alheety, AY Osama'a, S Shaaban, B Kibar, E Cacan Inorganic Chemistry Communications 121, 108193, 2020 | 37 | 2020 |
| Histone deacetylase-1-mediated suppression of FAS in chemoresistant ovarian cancer cells E Cacan Anticancer research 36 (6), 2819-2826, 2016 | 37 | 2016 |
| Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells A Kumari, E Cacan, SF Greer, C Garnett-Benson Journal for immunotherapy of cancer 1, 1-16, 2013 | 36 | 2013 |
| Regulator of G-protein Signaling 10 (RGS10) expression is transcriptionally silenced in activated microglia by histone deacetylase activity M Alqinyah, N Maganti, MW Ali, R Yadav, M Gao, E Cacan, HR Weng, ... Molecular Pharmacology, mol. 116.106963, 2017 | 32 | 2017 |
| Epigenetic‐mediated immune suppression of positive co‐stimulatory molecules in chemoresistant ovarian cancer cells E Cacan Cell Biology International, 2017 | 31 | 2017 |
| Antioxidant and cytotoxic activities of silver nanoparticles synthesized using Tilia cordata flowers extract KO Saygi, E Cacan Materials Today Communications 27, 102316, 2021 | 25 | 2021 |
| IL-7 signaling imparts polyfunctionality and stemness potential to CD4+ T cells ZC Ding, C Liu, Y Cao, T Habtetsion, M Kuczma, W Pi, H Kong, E Cacan, ... Oncoimmunology 5 (6), e1171445, 2016 | 24 | 2016 |
| Combination treatment with sublethal ionizing radiation and the proteasome inhibitor, bortezomib, enhances death-receptor mediated apoptosis and anti-tumor immune attack E Cacan, AM Spring, A Kumari, SF Greer, C Garnett-Benson International journal of molecular sciences 16 (12), 30405-30421, 2015 | 24 | 2015 |
| Radiation-induced modulation of immunogenic genes in tumor cells is regulated by both histone deacetylases and DNA methyltransferases E Cacan, SF Greer, C Garnett-Benson International journal of oncology 47 (6), 2264-2275, 2015 | 22 | 2015 |
| A collective analysis of lifespan-extending compounds in diverse model organisms, and of species whose lifespan can be extended the most by the application of compounds C Berkel, E Cacan Biogerontology 22 (6), 639-653, 2021 | 19 | 2021 |
| Transcriptomic analysis reveals tumor stage-or grade-dependent expression of miRNAs in serous ovarian cancer C Berkel, E Cacan Human Cell 34 (3), 862-877, 2021 | 19 | 2021 |
| Regulation of Fas in response to bortezomib and epirubicin in colorectal cancer cells E Cacan, ZC Ozmen Journal of Chemotherapy 32 (4), 193-201, 2020 | 18 | 2020 |
| DYNLL1 is hypomethylated and upregulated in a tumor stage-and grade-dependent manner and associated with increased mortality in hepatocellular carcinoma C Berkel, E Cacan Experimental and Molecular Pathology 117, 104567, 2020 | 17 | 2020 |
| GAB2 and GAB3 are expressed in a tumor stage-, grade-and histotype-dependent manner and are associated with shorter progression-free survival in ovarian cancer C Berkel, E Cacan Journal of cell communication and signaling 15 (1), 57-70, 2021 | 16 | 2021 |
| In silico analysis of DYNLL1 expression in ovarian cancer chemoresistance C Berkel, E Cacan Cell Biology International 44 (8), 1598-1605, 2020 | 16 | 2020 |
| The class II transactivator (CIITA) is regulated by post-translational modification cross-talk between ERK1/2 phosphorylation, mono-ubiquitination and Lys63 ubiquitination JE Morgan, RL Shanderson, NH Boyd, E Cacan, SF Greer Bioscience Reports 35 (4), e00233, 2015 | 16 | 2015 |
Caglar BerkelMolecular Biology and Genetics, Tokat Gaziosmanpasa Universitygop.edu.tr üzerinde doğrulanmış e-posta adresine sahip
